A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study
Objective. To determine the effectiveness and predictors of response to lumbar epidural corticosteroid injections (ESI) in patients with sciatica. We performed a 12-month, multicentre, double-blind, randomized, placebo-controlled, parallel-group trial in four secondary pain-care clinics in the Wessex Region.
Methods. Two hundred and twenty-eight patients with a clinical diagnosis of unilateral sciatica of 1–18 months’ duration were randomized to either three lumbar ESIs of triamcinolone acetonide or interligamentous saline injections at intervals of 3 weeks. The main outcome measure was the Oswestry low back pain disability questionnaire (ODQ).
Results. At 3 weeks, the ESI group demonstrated a transient benefit over the placebo group (patients achieving a 75% improvement in ODQ, 12.5 vs 3.7%; number needed to treat, 11.4). No benefit was demonstrated from 6 to 52 weeks. ESIs did not improve physical function, hasten return to work or reduce the need for surgery. There was no benefit of repeated ESIs over single injection. No clinical predictors of response were found. At the end of the study the majority of patients still had significant pain and disability regardless of intervention.
Conclusions. In this pragmatic study, ESIs offered transient benefit in symptoms at 3 weeks in patients with sciatica, but no sustained benefits in terms of pain, function or need for surgery. Sciatica is a chronic condition requiring a multidisciplinary approach. To fully investigate the value of ESIs, they need to be evaluated as part of a multidisciplinary approach.
sciatica, epidural injection, corticosteroids, pain, surgery
1399-1406
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Price, C.
534dbc54-63be-46a7-8394-479a4e1dc22d
Reading, I.
6f832276-87b7-4a76-a9ed-b4b3df0a3f66
Stubbing, J.
82f2ca29-85fa-415f-aa0a-eae6d7aebbdf
Hazelgrove, J.
96c6dc82-e221-4ed2-b8a8-ab5bc94458e5
Dunne, C.
96e618b0-df8d-4f46-841f-8d76d138c447
Michel, M.
560e6263-d080-4126-827a-8ad1b36764d4
Rogers, P.
0b9c2fba-91c2-417a-a1ea-4d84a3f6882a
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
2005
Arden, N.K.
23af958d-835c-4d79-be54-4bbe4c68077f
Price, C.
534dbc54-63be-46a7-8394-479a4e1dc22d
Reading, I.
6f832276-87b7-4a76-a9ed-b4b3df0a3f66
Stubbing, J.
82f2ca29-85fa-415f-aa0a-eae6d7aebbdf
Hazelgrove, J.
96c6dc82-e221-4ed2-b8a8-ab5bc94458e5
Dunne, C.
96e618b0-df8d-4f46-841f-8d76d138c447
Michel, M.
560e6263-d080-4126-827a-8ad1b36764d4
Rogers, P.
0b9c2fba-91c2-417a-a1ea-4d84a3f6882a
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Arden, N.K., Price, C., Reading, I., Stubbing, J., Hazelgrove, J., Dunne, C., Michel, M., Rogers, P. and Cooper, C.
(2005)
A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study.
Rheumatology, 44 (11), .
(doi:10.1093/rheumatology/kei028).
Abstract
Objective. To determine the effectiveness and predictors of response to lumbar epidural corticosteroid injections (ESI) in patients with sciatica. We performed a 12-month, multicentre, double-blind, randomized, placebo-controlled, parallel-group trial in four secondary pain-care clinics in the Wessex Region.
Methods. Two hundred and twenty-eight patients with a clinical diagnosis of unilateral sciatica of 1–18 months’ duration were randomized to either three lumbar ESIs of triamcinolone acetonide or interligamentous saline injections at intervals of 3 weeks. The main outcome measure was the Oswestry low back pain disability questionnaire (ODQ).
Results. At 3 weeks, the ESI group demonstrated a transient benefit over the placebo group (patients achieving a 75% improvement in ODQ, 12.5 vs 3.7%; number needed to treat, 11.4). No benefit was demonstrated from 6 to 52 weeks. ESIs did not improve physical function, hasten return to work or reduce the need for surgery. There was no benefit of repeated ESIs over single injection. No clinical predictors of response were found. At the end of the study the majority of patients still had significant pain and disability regardless of intervention.
Conclusions. In this pragmatic study, ESIs offered transient benefit in symptoms at 3 weeks in patients with sciatica, but no sustained benefits in terms of pain, function or need for surgery. Sciatica is a chronic condition requiring a multidisciplinary approach. To fully investigate the value of ESIs, they need to be evaluated as part of a multidisciplinary approach.
This record has no associated files available for download.
More information
Published date: 2005
Keywords:
sciatica, epidural injection, corticosteroids, pain, surgery
Identifiers
Local EPrints ID: 25204
URI: http://eprints.soton.ac.uk/id/eprint/25204
ISSN: 1462-0324
PURE UUID: bd427f06-06b2-4ee9-89f4-5008f2ad27ec
Catalogue record
Date deposited: 07 Apr 2006
Last modified: 18 Mar 2024 02:50
Export record
Altmetrics
Contributors
Author:
C. Price
Author:
I. Reading
Author:
J. Stubbing
Author:
J. Hazelgrove
Author:
C. Dunne
Author:
M. Michel
Author:
P. Rogers
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics